眼结核的争议
本文综述眼结核诊断与治疗中的三大争议:诊断术语未标准化、检查方法全球异质且发病机制无共识、抗结核治疗启动与疗程无指南。作者建议先识别支持性眼部体征,再阶梯式使用核酸检测与干扰素γ释放试验等检查确认「确诊」病例,并呼吁全球眼科医生协作制定术语、一线检查及抗结核与皮质类固醇治疗共识。
要点
- 眼结核仍属推定临床诊断,需有支持性临床体征与检查且排除其他葡萄膜炎病因。
- 作者建议先识别支持性眼部体征,再阶梯式采用核酸检测与干扰素γ释放试验等检查确认「确诊」病例。
- 目前无眼结核抗结核治疗启动或疗程指南,需全球协作建立术语、一线检查与治疗共识。
核心结论
- 眼结核在缺乏其他可能葡萄膜炎病因时,仍为基于支持性临床体征与检查的推定临床诊断。
- 作者认为需标准化眼结核术语以便研究间比较,并需全球眼科医生协作就术语、一线检查及抗结核与皮质类固醇治疗达成共识。
研究设计与样本
- 本文为综述,讨论当前眼结核的三个争议。
主要发现
- 许多报告未明确眼结核诊断如何定义,也未说明是否纳入「 probable 」或「 possible 」诊断。
- 全球检查方法异质,目前对眼结核发病机制无一致意见。
- 目前无眼结核患者抗结核治疗启动或疗程的指南。
关键数值与推荐
- 作者提出的临床路径为:先识别支持性眼部体征,再阶梯式使用核酸检测与干扰素γ释放试验等检查,之后确认「确诊」眼结核病例。
临床怎么用
- 作者建议采用先识别支持性眼部体征、再阶梯式检查以确认「确诊」病例的临床路径。
- 作者呼吁全球眼科医生协作,就眼结核术语、一线检查及抗结核与皮质类固醇治疗制定共识。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Ocular tuberculosis still remains a presumptive, clinical diagnosis in the presence of supportive clinical signs and investigations, while in the absence of other possible causes of uveitis. The purpose of this review is to discuss three controversies of ocular tuberculosis today. First, it is unclear from many reports on how the diagnosis of ocular tuberculosis was defined, and if they included 'probable' or 'possible' diagnoses. Thus, there is a need to standardise the terminology used for ocular tuberculosis to allow for comparisons among studies. Second, the investigative approach is heterogeneous worldwide and there is currently no agreement on the pathogenesis of ocular tuberculosis. A suggested clinical approach involves first identifying supportive ocular signs, followed by a step-ladder approach of using various investigations such as nucleic acid amplification tests and interferon-γ release assays, before confirming a 'definite' case of ocular tuberculosis. Third, there are currently no guidelines for the commencement or duration of antitubercular therapy in patients with ocular tuberculosis. The current review highlights the need for a collaboration from ophthalmologists around the world to establish a consensus on the terminology, guidelines on first-line investigations to use and guidance on antitubercular and corticosteroid therapy for ocular tuberculosis.
引用
- Ang M, Chee SP. Controversies in ocular tuberculosis. Br J Ophthalmol. 2016. PMID: 27815270. doi:10.1136/bjophthalmol-2016-309531
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。